Back to ACAD
Concurrent Investment Advisors, LLC → ACAD
Concurrent Investment Advisors, LLC ACAD Position History
Acadia Pharmaceuticals Inc. • Healthcare
Quarters held
12
Latest value
$543K
Q3 2026
Peak value
$659K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $346K |
| Q4 2025 | $502K |
| Q4 2025 | $659K |
| Q1 2026 | $540K |
| Q1 2026 | $114K |
| Q2 2026 | $564K |
| Q2 2026 | $145K |
| Q2 2026 | $6K |
| Q2 2026 | $506K |
| Q3 2026 | $510K |
| Q3 2026 | $14K |
| Q3 2026 | $543K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $543K | 3.1K | — | — |
| Q3 2026 | $14K | 703 | — | — |
| Q3 2026 | $510K | 25.3K | — | — |
| Q2 2026 | $506K | 2.9K | — | — |
| Q2 2026 | $6K | 36 | — | — |
| Q2 2026 | $145K | 5.7K | — | — |
| Q2 2026 | $564K | 22.3K | — | — |
| Q1 2026 | $114K | 5.1K | — | — |
| Q1 2026 | $540K | 24.3K | — | — |
| Q4 2025 | $659K | 24.7K | — | — |
| Q4 2025 | $502K | 18.8K | — | — |
| Q3 2025 | $346K | 16.2K | — | — |
Other funds holding ACAD
$377M
$322.9M
$302.7M
$247.8M
$229.6M
$229.6M
$211.3M
$202.4M